Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

565 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Neurological complications in HIV.
Hogan C, Wilkins E. Hogan C, et al. Among authors: wilkins e. Clin Med (Lond). 2011 Dec;11(6):571-5. doi: 10.7861/clinmedicine.11-6-571. Clin Med (Lond). 2011. PMID: 22268312 Free PMC article. Review.
Nevirapine use in HIV-1-infected children.
Verweel G, Sharland M, Lyall H, Novelli V, Gibb DM, Dumont G, Ball C, Wilkins E, Walters S, Tudor-Williams G. Verweel G, et al. Among authors: wilkins e. AIDS. 2003 Jul 25;17(11):1639-47. doi: 10.1097/00002030-200307250-00008. AIDS. 2003. PMID: 12853746
Antiretroviral treatments used among adults with HIV infection in Europe.
Colebunders R, Schrooten W, Dreezen C, Baratta C, Florence E, Finazzi R, Wilkins E, Hemmer R, Fleerackers Y, Andragetti R, Borchert M; Eurosupport Group. Colebunders R, et al. Among authors: wilkins e. AIDS Care. 2001 Feb;13(1):5-14. doi: 10.1080/09540120020018143. AIDS Care. 2001. PMID: 11177461
Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.
Sewell J, Daskalopoulou M, Nakagawa F, Lampe FC, Edwards S, Perry N, Wilkins E, O'Connell R, Jones M, Collins S, Speakman A, Phillips AN, Rodger AJ; Antiretrovirals, Sexual Transmission Risk and Attitudes (ASTRA) Study Group. Sewell J, et al. Among authors: wilkins e. HIV Med. 2017 Aug;18(7):463-473. doi: 10.1111/hiv.12477. Epub 2016 Dec 22. HIV Med. 2017. PMID: 28004523 Free PMC article.
Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy.
Stöhr W, Dunn DT, Arenas-Pinto A, Orkin C, Clarke A, Williams I, Johnson M, Beeching NJ, Wilkins E, Sanders K, Paton NI; Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) Trial Team. Stöhr W, et al. Among authors: wilkins e. AIDS. 2016 Nov 13;30(17):2617-2624. doi: 10.1097/QAD.0000000000001206. AIDS. 2016. PMID: 27456983 Clinical Trial.
Real-life outcomes of maraviroc-based regimens in HIV-1-infected individuals.
Babiker ZO, Douthwaite ST, Collier LE, Pennell A, Uriel AJ, Wilkins E. Babiker ZO, et al. Among authors: wilkins e. J Int Assoc Provid AIDS Care. 2013 Jan-Feb;12(1):12-4. doi: 10.1177/1545109712462454. Epub 2012 Oct 16. J Int Assoc Provid AIDS Care. 2013. PMID: 23076664 Free article.
Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults.
Cohen C, Wohl D, Arribas JR, Henry K, Van Lunzen J, Bloch M, Towner W, Wilkins E, Ebrahimi R, Porter D, White K, Walker I, Chuck S, De-Oertel S, Fralich T. Cohen C, et al. Among authors: wilkins e. AIDS. 2014 Apr 24;28(7):989-97. doi: 10.1097/QAD.0000000000000169. AIDS. 2014. PMID: 24508782 Clinical Trial.
565 results